RTOG 0617 Primary Objective
To compare the overall survival of patients treated
with high-dose versus standard-dose conformal
radiation therapy with concurrent chemotherapy.
To compare the overall survival of patients treated
with cetuximab versus without cetuximab with
concurrent chemoradiotherapy.